ArticleFrontiers in ophthalmology2026
Corneal neurotization for neurotrophic keratopathy: a case report of two patients from different age groups.
Article in Frontiers in ophthalmology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: To describe the techniques and the successful outcomes of corneal neurotization (CN) for the treatment of neurotrophic keratopathy (NK) in two patients from different age groups. Methods: A detailed clinical examination and comprehensive systemic workup were performed to determine the etiology of NK. Both cases were managed surgically with CN and followed for 3 years postoperatively at the King Khaled Eye Specialist Hospital & Research Center, Riyadh, Saudi Arabia. Results: Two eyes of a 66-year-old male and a 22-month-old boy who were diagnosed with NK and refractory to conservative therapy underwent CN. The first patient underwent indirect corneal neurotization for the management of NK in the right eye from the ipsilateral infraorbital nerve using a sural nerve interposition graft from the left leg, while the second patient underwent indirect corneal neurotization for the management of NK in the left eye from the contralateral right supraorbital nerve using a sural nerve interposition graft from the left leg. The symptoms improved following the procedure as well as the corneal sensation, with improvement of the NK in both patients. At the three-year follow-up, our patients showed no complications or NK recurrence. Conclusions: CN is a valuable surgical technique for the management of recalcitrant NK and possibly for restoring corneal sensation in some with NK prior to the development of irreversible stromal damage.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.